Phase IB dose-escalation and expansion study of AKT kinase inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer by Blagden, S, Hamilton, A, Mileshkin, L, Wong, S, Michael, A, Hall, M, Goh, J, Lisyanskaya, A, Desilvio, M, Frangou, E, Stronach, E, Gopalakrishna, P, Meniawy, T, Gabra, H